Are you Dr. Swaby?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 80 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
333 Cottman Ave
Fox Chase Cancer Center
Philadelphia, PA 19111Phone+1 214-728-6900Fax+1 215-214-1425
Summary
- Dr. Ramona Swaby, MD is an oncologist in Philadelphia, Pennsylvania. She is currently licensed to practice medicine in Pennsylvania. She is affiliated with Fox Chase Cancer Center.
Education & Training
University of Texas Health Science Center at HoustonFellowship, Hematology and Medical Oncology, 1999 - 2002
University of MarylandResidency, Internal Medicine, 1996 - 1999
University of Maryland School of MedicineClass of 1996
Certifications & Licensure
PA State Medical License 1999 - 2012
Clinical Trials
- Vorinostat and Trastuzumab in Treating Patients With Metastatic or Locally Recurrent Breast Cancer Start of enrollment: 2006 Aug 01
- Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer Start of enrollment: 2007 Nov 02
- Estrogen in Postmenopausal Women With ER Positive Metastatic Breast Cancer After Failure of Sequential Endocrine Therapy Start of enrollment: 2008 Apr 01
Publications & Presentations
PubMed
- 1 citationsPembrolizumab Plus Carboplatin and Paclitaxel as First-Line Therapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (KEYNOTE-B10): A Single-Arm Phase IV...Marcin Dzienis, Juan Cundom, Christian Sebastian Fuentes, Anna Spreafico, Melanie Nordlinger
Journal of Clinical Oncology. 2024-09-01 - Pembrolizumab plus epacadostat in patients with recurrent/metastatic head and neck squamous cell carcinoma (KEYNOTE-669/ECHO-304): a phase 3, randomized, open-label st...Byoung Chul Cho, Irene Braña, Beatriz Cirauqui, Sercan Aksoy, Felix Couture
BMC Cancer. 2024-07-25 - 13 citationsPembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head ...Jean-Pascal Machiels, Yungan Tao, Lisa Licitra, Barbara Burtness, Makoto Tahara
The Lancet. Oncology. 2024-05-01
Press Mentions
Kathy D Miller, MDJuly 7th, 2018
